Ironwood Pharmaceuticals IRWD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $296.15M-15.7% | $351.41M-20.6% | $442.74M+7.8% | $410.6M-0.8% | ||
| $95.14M-14.6% | $111.42M-4.0% | $116.09M+162% | $44.27M-37.1% | ||
| $82.26M-43.0% | $144.27M-8.9% | $158.31M+36.5% | $115.99M+4.4% | ||
| $197.65M-23.5% | $258.29M-81.4% | $1.39B+766% | $160.26M-11.7% | ||
| $98.5M+5.8% | $93.12M+109% | -$983.02M-493% | $250.34M+7.8% | ||
| 33.3%+6.8pp | 26.5%+249pp | -222%-283pp | 61%+4.8pp | ||
| $32.75M-0.9% | $33.03M+52.7% | $21.63M+185% | $7.6M-75.6% | ||
| $4.08M-8.8% | $4.47M-76.4% | $18.97M+99.7% | $9.5M+1,209% | ||
| -$28.48M-2.0% | -$27.93M-958% | -$2.64M-227% | $2.09M+107% | ||
| $70.03M+7.4% | $65.2M+107% | -$978.43M-488% | $252.42M+25.8% | ||
| $46.01M-28.5% | $64.32M-23.0% | $83.49M+7.9% | $77.36M+123% | ||
| $24.02M+2,629% | $880K+100% | -$1B-672% | $175.07M-66.9% | ||
| 8.1%+7.9pp | 0.3%+227pp | -226.4%-269pp | 42.6%-85.1pp | ||
| $0.13+1,400% | -$0.01+99.8% | -$6.51-771% | $0.97-70.0% | ||
| $0.16+1,700% | -$0.01+99.8% | -$6.45-666% | $1.14-65.0% | ||
| 678.6M+6.5% | 637M-6.9% | 684.4M-8.2% | 745.2M+13.7% | ||
| 646.8M+1.8% | 635.5M+2.3% | 621.1M+0.4% | 618.6M-4.5% | ||
| $42.55M-37.5% | $68.09M-6.3% | $72.64M+10.5% | $65.74M+120% | ||
| $1.88M-6.5% | $2.01M+27.7% | $1.58M+11.1% | $1.42M-6.9% | ||
| —— | —— | —— | —— | ||
| $3.54M-57.9% | $8.41M-15.5% | $9.95M+115% | $4.62M+33.7% | ||
| $6.52M+132% | -$20.28M— | —— | —— | ||
| -$35.15M— | —— | —— | —— | ||
| -$2.37M-9.0% | -$2.18M-9.1% | -$2M-2.5% | -$1.95M-6.1% | ||
| $4.11M+140% | -$10.26M— | —— | $10.82M+952% | ||
| -$447K— | —— | —— | -$153K-368% | ||
| -$367K— | —— | -$4.22M-30.9% | -$3.22M-436% | ||
| $30.33M-6.8% | $32.56M+140% | $13.55M+136% | $5.75M-20.4% | ||
| $4.08M-8.8% | $4.47M-76.4% | $18.97M+99.7% | $9.5M+1,209% | ||
| $216K+100% | -$106.97M— | —— | -$237.55M-5,121% | ||
| -$35K+75.4% | -$142K+100.0% | -$1.03B-754,546% | -$136K+48.7% | ||
| —— | $103.55M-43.5% | $183.43M-33.0% | $273.76M+4.5% | ||
| $1.69M+8.3% | $1.56M— | —— | —— | ||
| $193K-69.8% | $640K— | —— | —— | ||
| $35K-75.4% | $142K-48.0% | $273K+101% | $136K-48.7% | ||
| $216K-98.0% | $11.01M+73.2% | $6.36M— | —— | ||
| $20.51M+691% | $2.59M-85.8% | $18.32M— | —— | ||
| $296.15M-15.7% | $351.41M-20.6% | $442.74M+7.8% | $410.6M-0.8% | ||
| $17.25M-42.2% | $29.85M-6.7% | $32.01M+18.3% | $27.05M+21.4% | ||
| $98.5M+5.8% | $93.12M+109% | -$983.02M-493% | $250.34M+7.8% | ||
| $100.38M+6.4% | $94.32M+110% | -$981.82M-490% | $251.74M+7.7% | ||
| $100.38M+6.4% | $94.32M+110% | -$981.82M-490% | $251.74M+7.7% | ||
| 33.9%+7.1pp | 26.8%+249pp | -221.8%-283pp | 61.3%+4.8pp | ||
| $98.5M+5.8% | $93.12M+109% | -$983.02M-493% | $250.34M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ironwood Pharmaceuticals's revenue?
- Ironwood Pharmaceuticals (IRWD) generated $361.5M in revenue over the trailing twelve months, up 13.8% year over year.
- Is Ironwood Pharmaceuticals profitable?
- Ironwood Pharmaceuticals reported $102.2M in net income over the trailing twelve months, a 28.3% net margin.
- What are Ironwood Pharmaceuticals's profit margins?
- Gross margin is 99.2% and operating margin is 55.4%, with a 28.3% net margin.
- What is Ironwood Pharmaceuticals's earnings per share?
- Ironwood Pharmaceuticals's diluted EPS over the trailing twelve months is $0.60.
- Where does Ironwood Pharmaceuticals's income statement data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
